Anavo Therapeutics has appointed Dr. Edward Holson, Ph.D., as the Chief Scientific Officer (CSO) and President of Anavo US
Company Information
Company
Anavo Therapeutics
Location
Leiden, South Holland, Netherlands
About
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades.
We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications.
Fundz sees it the moment Anavo Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LeidenBiotechnologyHealth CareTherapeutics